DeepDyve – unlimited articles from the top peer-reviewed journals – Just $9.99/month.

Stay on top of your field and complete your research – Get started with a Free Trial. Signup only takes 60 seconds!

Inflammatory Liver Steatosis Caused by IL-12 and IL-18

Details

Publisher
Mary Ann Liebert, Inc.
Copyright
Copyright 2003 Mary Ann Liebert, Inc.
Subject
Articles
ISSN
1079-9907
eISSN
1079-9907
D.O.I.
10.1089/107999003321532493
Publisher site
See Article on Publisher Site

Preview Only

Expand Tray Hide Tray

Inflammatory Liver Steatosis Caused by IL-12 and IL-18

Abstract

Acute fatty degeneration in the liver is caused by various agents, such as aspirin, valproic acid, and ibuprofen, that directly inhibit mitochondrial beta-oxidation of fatty acid and oxidative phosphorylation. Endogenous molecules, such as cytokines and hormones, are also known to mediate microvesicular steatosis in liver failure. In this study, we examined how interleukin-12 (IL-12) and IL-18 cause steatosis in the liver. Administration of these cytokines in combination caused marked hepatosteatosis and weight loss in mice. There were marked increases in levels of interferon- γ (IFN- γ ), nitrite (NO 2 /NO 3 ), and fibrinogen in the circulation in these mice. On the other hand, the ATP concentration and blood flow in the liver were significantly reduced. These changes, except the production of IFN- γ and NO, were partially inhibited by Z-VAD-fmk, a synthetic tripeptide inhibitor for NO-induced caspases. These results indicate that IL-12 and IL-18 may mediate inflammatory hepatosteatosis through impairment of the microcirculation, which leads to mitochondrial dysfunction in hepatocytes.
Loading next page...

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/mary-ann-liebert/inflammatory-liver-steatosis-caused-by-il-12-and-il-18-g2HwAc05BD